SCHEMBL25560780

SCHEMBL25560780

CCN(CC)c1ccc([C@H](C)N(C)c2ccc(Br)cc2)cn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.56
TRPM5 Q9NZQ8 1/20 0.38
ALDH1A1 P00352 3/20 0.36
NPC1 O15118 2/20 0.36
MAPK1 P28482 2/20 0.36
KDM4E B2RXH2 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KCNH2 Q12809 3/20 0.35
PYCR1 P32322 1/20 0.35
CRHR1 P34998 1/20 0.34
S1PR1 P21453 1/20 0.33
MYC P01106 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
AOC3 Q16853 1/20 0.32
RAB9A P51151 1/20 0.31
CHRM2 P08172 2/20 0.31
CHRM1 P11229 2/20 0.31
DRD1 P21728 2/20 0.31
SLC6A2 P23975 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23930230 0.88 GBA1 (0.67) GBA1TRPM5ALDH1A1NPC1MAPK1
SCHEMBL23930232 0.88 GBA1 (0.67) GBA1TRPM5ALDH1A1NPC1MAPK1
SCHEMBL13466402 0.77 GBA1 (0.56) GBA1NPC1CRHR1MYCKMT2A
SCHEMBL17316578 0.74 GBA1 (1.00) GBA1TRPM5ALDH1A1NPC1MAPK1
SCHEMBL30175347 0.70 GBA1 (0.41) GBA1ALDH1A1NPC1SMN1; SMN2PYCR1
SCHEMBL23930192 0.70 GBA1 (0.41) GBA1ALDH1A1NPC1SMN1; SMN2PYCR1
SCHEMBL23930009 0.70 GBA1 (0.41) GBA1ALDH1A1NPC1SMN1; SMN2PYCR1
SCHEMBL15247185 0.70 GBA1 (0.44) GBA1ALDH1A1MAPK1KDM4ESMN1; SMN2
SCHEMBL30175324 0.69 GBA1 (0.41) GBA1KCNH2AOC3
SCHEMBL23929887 0.69 GBA1 (0.41) GBA1KCNH2AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159523-A1 PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF SHENZHEN ZHONGGE BIOLOGICAL TECHNOLOGY CO., LTD. (CN) 2023-05-25 US disclosed
US-20230159523-A1 PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF SHENZHEN ZHONGGE BIOLOGICAL TECHNOLOGY CO., LTD. (CN) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159523-A1 PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF NCOA4, CCDC47, CCDC6 GBA1 3054/4885TRPM5 3656/4885ALDH1A1 2273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.